Hsbc Holdings PLC Xencor Inc Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

A detailed history of Hsbc Holdings PLC transactions in Xencor Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 10,750 shares of XNCR stock, worth $219,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,750

Previous 13,016 17.41%

Holding current value

$219,945

Previous $288,000 29.51%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$18.21 - $24.5 $41,263 - $55,517	-2,266 Reduced 17.41%	10,750 $203,000
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $242,748 - $345,184	13,016 New	13,016 $288,000
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $212,667 - $268,905	10,591 New	10,591 $213,000
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $113,984 - $141,894	4,598 Added 48.33%	14,112 $367,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $75,361 - $99,298	-3,061 Reduced 24.34%	9,514 $252,000
Q2 2022 Aug 11, 2022	SELL	$19.74 - $29.01 $19,404 - $28,516	-983 Reduced 7.25%	12,575 $348,000
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $361,727 - $564,419	13,558 New	13,558 $369,000
Q2 2021 Aug 13, 2021	SELL	$34.33 - $44.68 $188,231 - $244,980	-5,483 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$40.81 - $53.88 $186,011 - $245,585	-4,558 Reduced 45.39%	5,483 $236,000
Q4 2020 Feb 12, 2021	SELL	$36.63 - $47.63 $22,087 - $28,720	-603 Reduced 5.67%	10,041 $438,000
Q3 2020 Nov 12, 2020	SELL	$30.09 - $43.02 $142,115 - $203,183	-4,723 Reduced 30.73%	10,644 $418,000
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $168,364 - $202,692	6,065 Added 65.2%	15,367 $498,000
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $58,863 - $107,512	2,845 Added 44.06%	9,302 $271,000
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $211,466 - $267,513	6,457 New	6,457 $220,000

Others Institutions Holding XNCR

# of Institutions

204

Shares Held

63.1M

Call Options Held

3.9K

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.22B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Xencor Inc Transaction History